-- CD BioSciences unveiled a complete portfolio of tailored zebrafish (Danio rerio) aging model development and analytical services, addressing rising global demand for robust in vivo platforms to dissect aging biology, age-related cognitive decline, and therapeutic interventions for degenerative disorders.
Against a backdrop of extended human lifespans and limited understanding of long-term anti-aging therapeutic efficacy, zebrafish have emerged as a gold-standard preclinical organism. The species undergoes gradual aging that parallels human physiological and behavioral shifts, paired with mature molecular and genetic toolkits to decode cellular drivers of age-associated cognitive impairment. CD BioSciences’ newly expanded service suite integrates genetic, dietary, and pharmacological aging induction strategies, delivering flexible, reproducible model systems for academic labs and pharmaceutical drug developers alike.
Leveraging Tol2 transposon insertional mutagenesis alongside CRISPR-Cas9 genome editing, CD BioSciences generates CRISPR-Cas9 transgenic zebrafish aging models with either accelerated or prolonged lifespans. Researchers can precisely modulate conserved longevity signaling axes including sirtuin pathways, insulin/IGF-1 cascades, and cellular senescence programs. Complementary transient gene modulation tools, such as Morpholino antisense oligonucleotides and in vitro transcribed capped mRNA microinjection, are also available for embryonic and adult-stage target gene silencing, enabling granular functional validation of aging-related genes.
Complementing genetically modified lines, CD BioSciences engineers pharmacologically-induced and diet-induced premature senescence zebrafish to recapitulate environmentally driven aging phenotypes. For dietary induction, customized high-calorie, high-fat, or nutrient-deficient feeding regimens reliably trigger early senescence and the full spectrum of age-linked pathological traits. Pharmacological aging induction relies on well-characterized agents including rapamycin, allowing controlled onset of aged physiological states without permanent genomic alteration. This dual induction system lets clients disentangle environmental and genetic contributions to senescence, supporting mixed-factor disease modeling that mirrors the multifactorial origins of human age-related illnesses.
Beyond model construction, CD BioSciences delivers end-to-end phenotypic profiling workflows. Comprehensive quantitative assays and in vivo imaging pipelines quantify age-related changes spanning physical function, cognitive performance, tissue histopathology and senescence biomarkers, tracking the progressive timeline of aging at cellular and organismal levels. The customizable platforms further support complex age-related disease modeling, combining genetic, dietary, and pharmaceutical triggers to recapitulate neurodegenerative, cardiovascular, and other late-onset pathologies for translational research.
With decades of collective expertise in aquatic model organism engineering and geroscience research, CD BioSciences unifies model generation, phenotypic analysis, and translational drug testing under one integrated service pipeline. All generated zebrafish aging models and supporting analytical assays are exclusively for preclinical laboratory investigation. Researchers and pharmaceutical developers seeking custom aging model solutions can directly contact CD BioSciences’ technical support team for project consultation.
About CD BioSciences
CD BioSciences is a leading global supplier of tailored preclinical animal model development, molecular biology testing, and translational research services. It specializes in custom aging, disease and transgenic model systems across multiple aquatic and mammalian species, supporting target validation, mechanism exploration, and small-molecule therapeutic screening for academic, biotech, and pharmaceutical partners worldwide.
Contact Info:
Name: Kikiwi Davis
Email: Send Email
Organization: CD BioSciences
Website: https://www.agingclocks.com/drug-development/
Release ID: 89198291
Google
RSS